“Ischemia modified albumin (IMA) and albumin adjusted-IMA (AAIMA) as biomarkers for diabetic retinopathy”, Nep J Oph, vol. 7, no. 2, pp. 117–123, May 2016, doi: 10.3126/nepjoph.v7i2.14960.